Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial-Reference-Cited by-同舟云学术

Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

Published:2024-07 Issue:7 Volume:60 Page:417-422
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:en
Short-container-title:Archivos de Bronconeumología

Author:

Agusti Alvar,Lopez-Campos José Luis,Miravitlles Marc,Soler-Cataluña Juan Jose,Marin Jose Maria,Cosio Borja G.,Alcázar-Navarrete Bernardino,Echave-Sustaeta Jose Maria,Casanova Ciro,Peces-Barba German,de-Torres Juan Pablo,Fernandez-Villar Alberto,Ancochea Julio,Villar-Alvarez Felipe,Roman-Rodriguez Miguel,Molina Jesus,Garcia-Rivero Juan Luis,Gonzalez Cruz,Sobradillo Patricia,Faner Rosa,Peña Carolina,Sharma Raj,Izquierdo José Luis,Celli Bartolome R.

Funder

GSK

Publisher

Elsevier BV

Reference24 articles.

1. Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary;Agustí;Arch Bronconeumol,2023

2. Exacerbation risk and mortality in global initiative for chronic obstructive lung disease group A and B patients with and without exacerbation history;Vanfleteren;Am J Respir Crit Care Med,2023

3. Blood eosinophils and chronic obstructive pulmonary disease: a Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review;Singh;Am J Respir Crit Care Med,2022

4. Outcomes for COPD pharmacological trials: from lung function to biomarkers;Cazzola;Eur Respir J,2008

5. An update on outcomes for COPD pharmacological trials: a COPD investigators report – reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials;Cazzola;Am J Respir Crit Care Med,2023